Abstract

BackgroundSocial anxiety disorder is a highly prevalent and burdensome condition. Persons with social anxiety frequently avoid seeking physician support and rarely receive treatment. Social anxiety symptoms are frequently underreported and underrecognized, creating a barrier to the accurate assessment of these symptoms. Consequently, more research is needed to identify passive biomarkers of social anxiety symptom severity. Digital phenotyping, the use of passive sensor data to inform health care decisions, offers a possible method of addressing this assessment barrier.ObjectiveThis study aims to determine whether passive sensor data acquired from smartphone data can accurately predict social anxiety symptom severity using a publicly available dataset.MethodsIn this study, participants (n=59) completed self-report assessments of their social anxiety symptom severity, depressive symptom severity, positive affect, and negative affect. Next, participants installed an app, which passively collected data about their movement (accelerometers) and social contact (incoming and outgoing calls and texts) over 2 weeks. Afterward, these passive sensor data were used to form digital biomarkers, which were paired with machine learning models to predict participants’ social anxiety symptom severity.ResultsThe results suggested that these passive sensor data could be utilized to accurately predict participants’ social anxiety symptom severity (r=0.702 between predicted and observed symptom severity) and demonstrated discriminant validity between depression, negative affect, and positive affect.ConclusionsThese results suggest that smartphone sensor data may be utilized to accurately detect social anxiety symptom severity and discriminate social anxiety symptom severity from depressive symptoms, negative affect, and positive affect.

Highlights

  • Social anxiety disorder (SAD) affects approximately 13% of Americans [1]

  • The results suggested that these passive sensor data could be utilized to accurately predict participants’ social anxiety symptom severity (r=0.702 between predicted and observed symptom severity) and demonstrated discriminant validity between depression, negative affect, and positive affect

  • On the basis of previous validated cutoffs, 36% (21/59) of the sample was above the primary cutoff, suggesting they were at clinical levels of SAD

Read more

Summary

Introduction

Background Social anxiety disorder (SAD) affects approximately 13% of Americans [1]. It is characterized by an intense, persistent, and exaggerated fear of evaluation or scrutiny in social situations and associated with behavioral avoidance [2]. Individuals with SAD symptoms are at increased risk for developing depressive disorders [4], with comorbidity rates estimated between 30% and 70% in clinical and community samples [5,6,7]. Persons with social anxiety frequently avoid seeking physician support and rarely receive treatment. Social anxiety symptoms are frequently underreported and underrecognized, creating a barrier to the accurate assessment of these symptoms. More research is needed to identify passive biomarkers of social anxiety symptom severity. The use of passive sensor data to inform health care decisions, offers a possible method of addressing this assessment barrier

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call